Effects and safety of dapagliflozin in paediatric hereditary kidney disease: protocol for a multicentric, prospective, open and randomised crossover study (DAPA-PedHKD)
Authors
Weili Yan (ORCID: https://orcid.org/0000-0002-7633-7449)
Effects and safety of dapagliflozin in paediatric hereditary kidney disease: protocol for a multicentric, prospective, open and randomised crossover study (DAPA-PedHKD)
Weili Yan, Yihui Zhai, Tianyi Liu, Yalan Dou et al.
Journal
BMJ Open
Topics
Diabetes Treatment and Management
article
Effects and safety of dapagliflozin in paediatric hereditary kidney disease: protocol for a multicentric, prospective, open and randomised crossover study (DAPA-PedHKD)
Weili Yan, Yihui Zhai, Tianyi Liu, Yalan Dou, Hong Xu, Wei Zhang, Qian Shen, Jiaojiao Liu
article en
Abstract
No abstract available for this paper.
Publication Tag
BMJ OpenVol. 15(12)
Institutions
Children's Hospital of Fudan University (CN), Kidney Centre (PK)
Funders
Shanghai Municipal Health Commission, Shanghai Municipal Education Commission